Loading...
XSHG603363
Market cap443mUSD
Dec 25, Last price  
3.78CNY
1D
5.00%
1Q
9.25%
IPO
-35.26%
Name

Fujian Aonong Biological Technology Group Incorporation Ltd

Chart & Performance

D1W1MN
XSHG:603363 chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
9.16%
Rev. gr., 5y
27.56%
Revenues
19.46b
-9.97%
2,953,809,5214,184,442,7044,012,709,1174,978,470,5984,902,660,0985,761,891,9485,788,080,06711,517,165,75718,038,160,16021,613,039,52119,457,641,131
Net income
-3.65b
24,991,36442,745,07133,776,93691,375,506108,118,86630,125,654100,356,032993,605,03300-3,650,822,227
CFO
984m
+48.27%
00129,237,958128,952,36826,775,90027,261,152394,159,196406,022,923524,291,286663,636,691984,006,832
Dividend
Jun 08, 20210.15 CNY/sh
Earnings
Jun 06, 2025

Profile

Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig raising, raw materials trade, agricultural internet, bio-pharmaceutical, and other businesses in China and internationally. The company researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant feed, and other products; operates pig breeding farms; and engages in the pig slaughtering and processing activities. It also provides vaccines, veterinary drug preparations, micro ecological preparations, powders, premixes, oral liquids, additives, disinfectants, and other products, as well as creates intelligent breeding service platform. The company was founded in 2011 and is based in Xiamen, China.
URL
http://www.aonong.com.cn/
IPO date
Sep 26, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
19,457,641
-9.97%
21,613,040
19.82%
18,038,160
56.62%
Cost of revenue
21,418,175
21,407,246
18,399,042
Unusual Expense (Income)
NOPBT
(1,960,534)
205,794
(360,882)
NOPBT Margin
0.95%
Operating Taxes
87,053
29,343
Tax Rate
NOPAT
(2,047,587)
205,794
(390,225)
Net income
(3,650,822)
 
Dividends
(373,665)
(102,821)
Dividend yield
3.74%
1.47%
Proceeds from repurchase of equity
(8,442)
(1)
BB yield
0.16%
0.00%
Debt
Debt current
5,044,465
5,866,745
4,737,019
Long-term debt
3,508,051
4,640,350
6,031,843
Deferred revenue
380,189
147,267
109,365
Other long-term liabilities
25,163
302,950
181,842
Net debt
8,008,659
9,481,608
10,050,526
Cash flow
Cash from operating activities
984,007
663,637
524,291
CAPEX
(511,774)
Cash from investing activities
(274,925)
Cash from financing activities
(1,177,615)
1,220,175
2,199,634
FCF
2,037,810
(708,211)
(3,342,534)
Balance
Cash
212,264
721,688
543,983
Long term investments
331,593
303,799
174,353
Excess cash
Stockholders' equity
(4,116,098)
1,842,232
1,673,745
Invested Capital
11,407,505
12,808,222
11,659,861
ROIC
1.68%
ROCE
1.60%
EV
Common stock shares outstanding
867,179
775,393
550,559
Price
6.07
-52.91%
12.89
1.50%
12.70
2.50%
Market cap
5,263,775
-47.33%
9,994,813
42.94%
6,992,095
-10.37%
EV
13,732,186
20,404,569
17,932,140
EBITDA
(725,789)
1,495,422
681,578
EV/EBITDA
13.64
26.31
Interest
574,056
505,832
418,768
Interest/NOPBT
245.80%